Literature DB >> 17612685

Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics.

M J Kofflard1, M Michels, R Krams, M Kliffen, M L Geleijnse, F J Ten Cate, P W Serruys.   

Abstract

BACKGROUND.: The decrease in coronary flow reserve (CFR) in hypertrophic cardiomyopathy (HCM) predisposes to myocardial ischaemia, systolic dysfunction and cardiac death. In this study we investigate to which extent haemodynamic, echocardiographic, and histological parameters contribute to the reduction of CFR. METHODS.: In ten HCM patients (mean age 44+/-14 years) and eight heart transplant (HTX) patients (mean age 51+/-6 years) CFR was calculated in the left anterior descending coronary artery. In all subjects haemodynamic, echocardiographic and histological parameters were assessed. The relationship between these variables and CFR was determined using linear regression analysis. RESULTS.: CFR was reduced in HCM compared with HTX patients (1.6+/-0.7 vs. 2.7+/-0.8, p<0.01). An increase in septal thickness (p<0.005), indexed left ventricular (LV) mass (p<0.005), LV end-diastolic pressure (p<0.001), LV outflow tract gradient (p<0.05) and a decrease in arteriolar lumen size (p<0.05) were all related to a reduction in CFR. CONCLUSION.: In HCM patients haemodynamic (LV end-diastolic pressure, LV outflow tract gradient), echocardiographic (indexed LV mass) and histological (% luminal area of the arterioles) changes are responsible for a decrease in CFR. (Neth Heart J 2007;15:209-15.).

Entities:  

Year:  2007        PMID: 17612685      PMCID: PMC1896141          DOI: 10.1007/BF03085982

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  31 in total

1.  Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics.

Authors:  M J Kofflard; M Michels; R Krams; M Kliffen; M L Geleijnse; F J Ten Cate; P W Serruys
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

Review 2.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

3.  Effects of adenosine on human coronary arterial circulation.

Authors:  R F Wilson; K Wyche; B V Christensen; S Zimmer; D D Laxson
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

4.  Difference in coronary blood flow dynamics between patients with hypertension and those with hypertrophic cardiomyopathy.

Authors:  Katsushi Misawa; Yutaka Nitta; Takao Matsubara; Kotaro Oe; Masaru Kiyama; Masami Shimizu; Hiroshi Mabuchi
Journal:  Hypertens Res       Date:  2002-09       Impact factor: 3.872

5.  Changes in phasic coronary blood flow velocity profile and relative coronary flow reserve in patients with hypertrophic obstructive cardiomyopathy.

Authors:  M K Kyriakidis; J M Dernellis; A E Androulakis; G A Kelepeshis; J Barbetseas; A N Anastasakis; A G Trikas; C A Tentolouris; J E Gialafos; P K Toutouzas
Journal:  Circulation       Date:  1997-08-05       Impact factor: 29.690

6.  Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries.

Authors:  B J Maron; S E Epstein; W C Roberts
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

7.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

8.  Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy.

Authors:  K Rakusan; M F Flanagan; T Geva; J Southern; R Van Praagh
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

9.  Phasic coronary flow characteristics in patients with hypertrophic cardiomyopathy: a study by coronary Doppler catheter.

Authors:  T Akasaka; J Yoshikawa; K Yoshida; K Maeda; T Takagi; S Miyake
Journal:  J Am Soc Echocardiogr       Date:  1994 Jan-Feb       Impact factor: 5.251

10.  Septal perforator compression (narrowing) in idiopathic hypertrophic subaortic stenosis.

Authors:  A D Pichard; J Meller; L E Teichholz; S Lipnik; R Gorlin; M V Herman
Journal:  Am J Cardiol       Date:  1977-09       Impact factor: 2.778

View more
  14 in total

1.  Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics.

Authors:  M J Kofflard; M Michels; R Krams; M Kliffen; M L Geleijnse; F J Ten Cate; P W Serruys
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

2.  Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis.

Authors:  Sharmila Dorbala; Divya Vangala; John Bruyere; Christina Quarta; Jenna Kruger; Robert Padera; Courtney Foster; Michael Hanley; Marcelo F Di Carli; Rodney Falk
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

3.  Angina Relief by Ranolazine Identifies False-Negative SPECT Myocardial Perfusion Scans in Patients with Coronary Disease Demonstrated by Coronary Angiography.

Authors:  Gary L Murray
Journal:  Int J Angiol       Date:  2014-09

Review 4.  Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Aurelio Sgalambro; Massimo Baldi; Barbara Sotgia; Davide Antoniucci; Paolo G Camici; Roberto Sciagrà; Iacopo Olivotto
Journal:  J Cardiovasc Transl Res       Date:  2009-11-03       Impact factor: 4.132

5.  Long-term prognostic value of coronary flow velocity reserve in patients with hypertrophic cardiomyopathy: 9-year follow-up results from SZEGED study.

Authors:  Attila Nemes; Erika Balázs; Osama I I Soliman; Róbert Sepp; Miklós Csanády; Tamás Forster
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

Review 6.  Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.

Authors:  Richard J Marszalek; R John Solaro; Beata M Wolska
Journal:  Pflugers Arch       Date:  2018-10-29       Impact factor: 3.657

7.  Insights into restrictive cardiomyopathy from clinical and animal studies.

Authors:  Pierre-Yves Jean-Charles; Yue-Jin Li; Chang-Long Nan; Xu-Pei Huang
Journal:  J Geriatr Cardiol       Date:  2011-09       Impact factor: 3.327

8.  New ESC guidelines on hypertrophic cardiomyopathy: new insights in invasive treatment?

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2015-01       Impact factor: 2.380

9.  Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes.

Authors:  Rui Si; Qian Zhang; Atsumi Tsuji-Hosokawa; Makiko Watanabe; Conor Willson; Ning Lai; Jian Wang; Anzhi Dai; Brian T Scott; Wolfgang H Dillmann; Jason X-J Yuan; Ayako Makino
Journal:  Cardiovasc Res       Date:  2020-05-01       Impact factor: 10.787

10.  Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.

Authors:  Rui Li; Zhi-gang Yang; Lin-yi Wen; Xi Liu; Hua-yan Xu; Qin Zhang; Ying-kun Guo
Journal:  J Cardiovasc Magn Reson       Date:  2016-04-06       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.